Thermo Fisher Scientific (TMO) Tax Provisions (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Tax Provisions for 18 consecutive years, with $167.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions rose 81.52% year-over-year to $167.0 million; the trailing twelve-month figure through Jun 2026 stood at $597.0 million (up 36.93% YoY), and the FY2025 full-year result was $547.0 million, down 16.74% from the prior year.
• Tax Provisions climbed to $167.0 million in Q2 2026 per TMO's latest filing, from $70.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $301.0 million in Q2 2022 and bottomed at $31.0 million in Q4 2022.
• Historically, Tax Provisions has averaged $134.9 million across 5 years, with a median of $130.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 88.56% in 2022, then surged 510.87% in 2024.
• Over 5 years, Tax Provisions stood at $173.0 million in 2022, then slipped by 23.12% to $133.0 million in 2023, then advanced by 12.78% to $150.0 million in 2024, then rose by 2.0% to $153.0 million in 2025, then gained by 9.15% to $167.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $167.0 million, $70.0 million, and $153.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.